Cellink is partner of the 3D Medical Printing Series

Cellink will exhibit during the 3D Medical Printing Series, and will have a speaker at the 3D Bioprinting Conference on 29 March. CELLINK is creating the future of health as part of BICO, the world’s leading bioconvergence company. At the forefront of the bioprinting industry, CELLINK aims to alleviate organ donor shortage with biofabricated transplantable organs and remains committed to reducing our dependence on animal testing and increasing efficiencies in drug development with more physiologically relevant bioprinted organ models.

History
By releasing the first universal bioink in 2016, we democratized the cost of entry for researchers around the world and played a major role in turning the then up-and-coming field of 3D bioprinting into the thriving $1 billion industry it is today.

Our best-in-class bioinks, bioprinters, software and services are being used by the foremost academics and R&D labs and have enabled critical breakthroughs in a wide range of applications from 3D cell culturing to tissue engineering to drug development.

CELLINK is dedicated to taking the on-demand biofabrication of human organs and tissues to the next level, in line with BICO’s vision to leverage bioconvergence in the life sciences and create the future of health.

The team
We leverage the talents and enthusiasm of more than 180 engineers, scientists, financial experts and sales and marketing specialists to nurture the research and development of innovative life-science products and technologies for a wide range of applications and industries.

Cellink will exhibit during the 3D Medical Printing Series, and will have a speaker at the 3D Bioprinting Conference on 29 March.

For more information about the company, please visit their website.

Leave a Reply

Your email address will not be published.